Aurion Biotech announced it has received regulatory approval from Japan’s Pharmaceuticals and Medical Devices Agency, for its novel cell therapy, VyznovaTM for the treatment of bullous keratopathy of the cornea.
[Aurion Biotech]
Home Newsletters Cell Therapy News Aurion Biotech Receives Approval From Japan’s PMDA For New Drug Application
